Adenosine-induced renal vasoconstriction in diabetes mellitus rats: Role of nitric oxide

American Journal of Physiology - Renal Physiology

Volumn 276, Issue 3 45-3, 1999, Pages

  Pflueger, Axel C ^a   Osswald, Hartmut ^b   Knox, Franklyn G ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Diabetic dysfunctional vasoregulation; Experimental insulin dependent diabetes mellitus; Nitric oxide dependent renal vasodilation; Renal hemodynamics; Renal ischemia

Indexed keywords

ADENOSINE; NITRIC OXIDE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DIABETES MELLITUS; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY PERFUSION; MEDIATOR RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM INTAKE; URETER OBSTRUCTION; VASOCONSTRICTION;

EID: 0032920076     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.1999.276.3.f340     Document Type: Article

References (41)

1. 1-receptors in glomerular membranes from rats with streptozotocin-induced diabetes mellitus (Abstract). Naunyn Schmiedebergs Arch. Pharmacol. 349: 114, 1994.
2. Bank, N., and H. S. Aynedjian. Role of EDRF (nitric oxide) in diabetic hyperfiltration. .Kidney Int. 43: 1306-1312, 1993.
3. Bohle, A., J. Christensen, F. Kobot, H. Osswald, B. Schubert, H. Kendziora, H. Pressler, and J. Marcovic Lipovski. Acute renal failure in man: new aspects concerning pathogenesis. Am. J. Nephrol. 10: 374-388, 1990.
4. Bucala, R., and H. Vlassara. Advanced glycosylation end products in diabetic renal and vascular disease. Am. J. Kidney Dis. 26: 875-888, 1995.
5. Calver, A., J. Collier, and P. Vallance. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J. Clin. Invest. 90: 2548-2554, 1992.
6. Carmines, P. K., K. Ohishi, and H. Ikenaga. Functional impairment of renal afferent arteriolar voltage-gated calcium channels in rats with diabetes mellitus. J. Clin. Invest. 98: 2564-2571, 1996.
7. Craven, P. A., R. K. Studer, and F. R. Derubertis. Impaired nitric-oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. J. Clin. Invest. 93: 311-320, 1994.
8. Dai, F. X., A. Diederich, J. Skopec, and D. Diederich. Diabetes-induced dysfunction in streptozotocin-treated rats: role of prostaglandin endoperoxides and free radicals. J. Am. Soc. Nephrol. 4: 1327-1336, 1993.
9. Derubertis, F. R., and P. A. Craven. Activation of protein kinase C in glomerular cells in diabetes. Mechanisms and potential links to the pathogenesis of diabetic glomerulopathy. Diabetes 43: 1-8, 1994.
10. Diederich, D. Nitric oxide in diabetic nephropathy. In: Nitric Oxide and the Kidney, edited by M. S. Gologorsky and S. S. Gross. New York: Chapman and Hall, 1997, p. 349-367.
11. Elliott, T. G., J. R. Cockcroft, P. H. Groop, G. C. Viberti, and J. M. Ritter. Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. Clin. Sci. (Colch.) 85: 687-693, 1993.
12. Erley, C. M., S. H. Duda, S. Schlepckow, J. Koehler, P. E. Huppert, W. L. Strohmaier, A. Bohle, T. Risler, and H. Osswald. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int. 45: 1425-1431, 1994.
13. + ATPase activity in rabbit aorta by hyperglycemia, Possible role of endothelium-derived nitric oxide. J. Clin. Invest. 90: 727-732, 1992.
14. Haak, T., E. Jungman, A. Felber, U. Hillman, and K. H. Usadel. Increased levels of endothelin in diabetic patients with hypertension. Am. J. Hypertens. 5: 161-166, 1992.
15. Haas, J. A., and H. Osswald. Adenosine induced fall in glomerular capillary pressure-effect of ureteral obstruction and aortic constriction in the Munich-Wistar rat kidney. Naunyn Schmiedebergs Arch. Pharmacol. 317: 86-89, 1981.
16. Hayashi, K., M. Epstein, R. Loutzenhiser, and H. Forster. Impaired myogenic responsiveness of the afferent arteriole in streptozotocin-induced diabetic rats: role of eicosanoid derangements. J. Am. Soc. Nephrol. 2: 1578-1586, 1992.
17. Hogan, M., A. Cerami, and R. Bucala. Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitus. J. Clin. Invest. 90: 1110-1115, 1992.
18. Hostetter, T. H., J. L. Troy, and B. M. Brenner. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int. 19: 410-415, 1981.
19. Ikeda, U., K. Yamamoto, Y. Maeda, M. Shimpo, T. Kanbe, and K. Shimada. Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells. Hypertension 29: 65-69, 1997.
20. Jensen, P. K., J. S. Christiansen, K. Steven, and H. H. Parving. Strict metabolic control and renal function in the streptozotocin diabetic rat. Kidney Int. 31: 47-51, 1987.
21. Kellet, R., C. J. Bowmer, M. G. Collis, and M. S. Yates. Amelioration of glycerol-induced acute renal failure in the rat with 8-cyclopentyl-1,3-dipropylxanthine. Br. J. Pharmacol. 98: 1066-1074, 1988.
22. Komers, R., T. J. Allen, and M. E. Cooper. Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 43: 1190-1197, 1994.
23. Langenstroer, P., and G. M. Pieper. Regulation of spontaneous EDRF release in diabetic rat aorta by oxygen free radicals. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H257-H265, 1992.
24. G-monomethyl-L-arginine. Circ. Res. 75: 829-835, 1994.
25. Lohse, M. J., K. N. Klotz, J. Lindenborn-Fotinos, M. Reddington, U. Schwabe, and R. A. Olsson. 8-Cyclopentyl-1,3-dipropylxanthine (DPCPX): a selective high affinity antagonist radioligand for A1 adenosine receptors. Naunyn Schmiedebergs Arch. Pharmacol. 336: 204-210, 1987.
26. McCoy, D. E., S. Bhattacharya, B. A. Olson, D. G. Levier, L. J. Arend, and W. S. Spielman. The renal adenosine system: structure, function, and regulation. Semin. Nephrol. 13: 31-40, 1993.
27. Melin, J., O. Hellberg, L. M. Akyuerek, O. Kaellskog, and E. Larsson. Ischemia causes rapidly progressive nephropathy in the diabetic rat. Kidney Int. 52: 985-991, 1997.
28. Ohishi, K., and P. K. Carmines. Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J. Am. Soc. Nephrol. 5: 1559-1566, 1995.
29. Okumura, M., K. Miura, Y. Yamashita, T. Yukimura, and K. Yamamoto. Role of endothelium-derived relaxing factor in the in vivo renal vascular action of adenosine in dogs. J. Pharmacol. Exp. Ther. 260: 1262-1267, 1992.
30. Osswald, H. Adenosine and renal function. In: Regulatory Function of Adenosine, edited by R. M. Berne, T. W. Rall, and R. Rubio. The Hague: Martinus Nijhof, 1983, p. 399-415.
31. Osswald, H., H. J. Schmitz, and R. Kemper. Tissue content of adenosine, inosine and hypoxanthine in the rat kidney after ischemia and postischemic recirculation. Pflügers Arch. 371: 45-49, 1977.
32. Pflueger, A. C., F. Schenk, and H. Osswald. Increased sensitivity of the diabetic renal vasculature to adenosine in streptozotocin-induced diabetes mellitus rats. Am. J. Physiol. 269 (Renal Fluid Electrolyte Physiol. 38): F529-F535, 1995.
33. Pieper, G. M., P. Langenstroer, and W. Siebeneich. Diabetic-induced endothelial dysfunction in rat aorta: role of hydroxyl radicals. Cardiovasc. Res. 34: 145-156, 1997.
34. Pieper, G. M. Review of alterations of endothelial nitric oxide production in diabetes protective role of arginine on endothelial dysfunction. Hypertension 31: 1047-1060, 1998.
35. Rudnick, M. R., S. Goldfarb, L. Wexler, P. A. Ludbrook, M. J. Murphy, E. F. Halpern, J. A. Hill, M. Winnford, M. B. Cohen, and D. B. Van Fossen. Nephrotoxicity of ionic contrast media in 1196 patients: a randomized trial. Kidney Int. 47: 254-261, 1995.
36. Scholey, J. W., and T. W. Meyer. Control of glomerular hypertension by insulin administration in diabetic rats. J. Clin. Invest. 83: 1384-1389, 1989.
37. Shafrir, E. Diabetes in animals. In: Ellenberg & Rifkin's Diabetes Mellitus (5th ed.), edited by D. Porte, Jr., and R. S. Sherwin. Stamford, CT: Appleton and Lange, 1997, p. 301-348.
38. Tesfamariam, B., M. L. Brown, and R. A. Cohen. Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J. Clin. Invest. 87: 1643-1648, 1991.
39. Tolins, J. P., P. J. Schultz, L. Raij, D. M. Brown, and S. M. Mauer. Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO. Am. J. Physiol. 265 (Renal Fluid Electrolyte Physiol. 34): F886-F895, 1993.
40. Wang, Y. X., D. P. Brooks, and R. M. Edward. Attenuated glomerular cGMP production and renal vasodilation in streptozotocin-induced diabetic rats. Am. J. Physiol. 264 (Regulatory Integrative Comp. Physiol. 33): R952-R956, 1993.
41. Weisberg, L. S., P. B. Kurnik, and B. R. Kurnik. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int. 45: 259-265, 1994.